Zacks23d agobullish
Gilead (GILD) Upgraded to Strong Buy: What Does It Mean for the Stock?Gilead (GILD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
144last 24h
877last 7d
147● bullish (7d)
98● bearish (7d)
214publishers
Insider Monkey114d agobullish
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue GrowthTempus AI, Inc. (NASDAQ:TEM) ranks among the best short squeeze stocks to invest in. Following the company’s first-quarter results, H.C. Wainwright reduced its price target for Tempus AI, Inc. (NASDAQ:TEM) to $64 from $95 while retaining a Buy rating on the company’s shares. Tempus AI, Inc. (NASDAQ:TEM) posted total revenue of $348.1 million in Q1, […]
Insider Monkey123d agobullish
Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’With an annual dividend yield of 2.50%, Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds. Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. On May […]